Beckley Psytech has dosed the first participant in their Phase I single-ascending dose (SAD) study of ELE-101, with top-line results expected in H1 2023. ELE-101 is a patent-protected, next-generation formulation of psilocin, the active metabolite of psilocybin, under clinical development for depression. ELE-101 is the second clinical-stage psychedelic compound in Beckley Psytech’s portfolio alongside BPL-003, … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce Sensorion’s management team participation, in-person, in Jefferies London Healthcare Conference, taking place in London, UK, on November … [Read more…]

Trial met its primary endpoint with Onivyde® (irinotecan liposome injection) in the NALIRIFOX treatment regimen showing statistically significant improvement in overall survival compared to nab-paclitaxel plus gemcitabine regimen Study met key secondary endpoint of progression-free survival with a safety profile consistent with the previous study Clinical trial results will be presented at an upcoming medical … [Read more…]

Formal Therapeutic Goods Administration (“TGA”) approval of BiomeBank’s first-generation donor derived microbiome-based therapy. BiomeBank to scale up its Good Manufacturing Practice (GMP) manufacturing facility to meet increasing global demand for its donor derived microbiome drug product -positioned for the treatment of recurrent C. difficile infection with a path to approval in additional conditions. ADELAIDE, Australia–(BUSINESS … [Read more…]

Hosting Call on Tuesday, November 15th at 5 pm ET TORONTO & DALLAS–(BUSINESS WIRE)–$PINK.V #AI–Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today announced it will … [Read more…]

EbvalloTM Positioned to be the First Allogeneic T-Cell Therapy Ever Approved Following CHMP Positive Opinion New ATA188 Biomarker Imaging Data Show Less Brain Atrophy and Possible Remyelination in Patients Achieving Confirmed Disability Improvement in Progressive MS Phase 1 Study of ATA2271 Enrollment Resumed Conference Call and Webcast Today at 1:30 p.m. PST / 4:30 p.m. … [Read more…]

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced operating results for the three months ended September 30, 2022. Financial Highlights Revenue of $26.6M for Q3 2022 was flat versus Q3 2021 with the prior year NIH RADx funding excluded, and increased 13% over Q2 2022. Pro-forma … [Read more…]

Reinforcing GLC’s Commitment to Sustainable Processing in Pharmaceutical Chemistry OAKVILLE, Ontario–(BUSINESS WIRE)–GL CHEMTEC (“GLC”), a specialist in advanced chemistry R&D and scale-up services to support Active Pharmaceutical Ingredient (“API”) development, and the development of advanced materials for drug delivery, biomedical materials, and other life science applications, today announced that it has appointed Dr. John Warner … [Read more…]

Funding will help the company create a SaaS platform and expand its sales and marketing teams BOSTON–(BUSINESS WIRE)–D.A. Davidson & Co. announced today that it served as exclusive financial advisor to IronRod Health (IronRod), an Arizona-based innovative remote health monitoring platform, on its investment from HCAP Partners. Since its founding in 2016, IronRod has helped … [Read more…]

Earning the Highest Honor for its Abuse Prevention Practices ARLINGTON, Texas–(BUSINESS WIRE)–Praesidium, a national leader in risk management and prevention of sexual abuse against vulnerable populations, proudly announced today that Merakey, a leading developmental behavioral health and education provider, has achieved Praesidium Accreditation, demonstrating their commitment to meeting and exceeding the highest industry standards in … [Read more…]